| 2023/03/27 17:44:20 | |
|---|---|
| Price | |
| 38.49 EUR | |
| Difference | 3.83% (1.42) |
General attributes
| ISIN | DE0005785802 |
| Symbol | FME |
| Exchange | Xetra |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 11,293 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 37.55 EUR |
| High | 38.65 EUR |
| Low | 37.41 EUR |
| Close (prev. day) | 37.07 EUR |
| VWAP | 38.34167 EUR |
| Volume (pcs) | 465,573 |
| Trading volume | 17,850,845.84 |
| Number of trades | 2,797 |
| Last size | 174 |
Futures and Options
| Related Futures | 38 |
| Related Options | - |
PDF Downloads
| Company report: FRESENIUS MEDICAL CARE AG & CO KGAA |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2023/03/16 |
|
Global Equity Ratings |
|
| 2023/03/10 |
|
Global Equity Ratings |
|
| 2023/02/27 |
|
Global Equity Ratings |
|
| 2023/02/07 |
|
Global Equity Ratings |
|
| 2023/01/30 |
|
Global Equity Ratings |
|
| 2023/03/27 17:44:20 | |
|---|---|
| Price | |
| 38.49 EUR | |
| Difference | 3.83% (1.42) |
General attributes
| ISIN | DE0005785802 |
| Symbol | FME |
| Exchange | Xetra |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 11,293 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 37.55 EUR |
| High | 38.65 EUR |
| Low | 37.41 EUR |
| Close (prev. day) | 37.07 EUR |
| VWAP | 38.34167 EUR |
| Volume (pcs) | 465,573 |
| Trading volume | 17,850,845.84 |
| Number of trades | 2,797 |
| Last size | 174 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +33.79% | -35.98% | -33.36% |
| Perf (abs.) | +9.72 | -21.63 | -19.27 |
| Beta | 0.73 | 0.54 | 0.56 |
| Volatility | 35.59 | 36.02 | 29.80 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 37.67 EUR (477,082) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 37.20 EUR (978,965) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 33.26 EUR (755,100) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 39.16 EUR (753,547) |
| YTD High | date | 42.21 EUR (2023/02/22) |
| YTD Low | date | 28.82 EUR (2023/01/03) |
| 52 Weeks High | date | 63.66 EUR (2022/04/21) |
| 52 Weeks Low | date | 25.95 EUR (2022/10/31) |
All listings for FRESENIUS MEDICAL CARE AG & CO KGAA
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2023/03/27 | 17:44 | 38.49 EUR | 17.85 | 2,797 |
| Vienna Stock Exchange | 2023/03/27 | 17:32 | 38.48 EUR | 0.00 | 2 |
| Tradegate | 2023/03/27 | 22:26 | 38.53 EUR | 0.85 | 127 |
| Stuttgart | 2023/03/27 | 21:55 | 38.43 EUR | 0.11 | 61 |
| SIX Swiss Exchange | 2019/06/25 | 17:31 | 75.28 CHF | 0.02 | 3 |
| SIX Swiss Exchange | - | - | - | 0.00 | - |
| Munich | 2023/03/27 | 10:54 | 38.20 EUR | 0.00 | 3 |
| London Stock Exchange European Trade Reporting | 2023/03/27 | 17:30 | 38.58 EUR | 0.00 | 2 |
| Hanover | 2023/03/27 | 08:07 | 37.34 EUR | 0.00 | 1 |
| Hamburg | 2023/03/27 | 08:56 | 37.55 EUR | 0.10 | 2 |
| Frankfurt | 2023/03/27 | 20:50 | 38.66 EUR | 0.02 | 7 |
| FINRA other OTC Issues | 2023/03/17 | 15:20 | 38.72 USD | 0.00 | 1 |
| Euronext Milan MTF GLobal Equity Market | 2023/03/27 | 17:44 | 36.64 EUR | 0.00 | 1 |
| Duesseldorf | 2023/03/27 | 08:10 | 37.21 EUR | 0.00 | 1 |
| Berlin | 2023/03/27 | 21:52 | 38.52 EUR | 0.00 | 16 |
| BX Swiss | 2023/03/24 | 18:00 | 36.00 CHF | 0.00 | 1 |
Company Logo
Contact Details
| FRESENIUS MEDICAL CARE AG & CO. KGAA |
| - - |
| Else-Kröner-Strasse 1 - 61352 Bad Homburg |
| Telefon: +49-6172-609-0 |
| Fax: +49-6172-609-2301 |
| E-mail: marketing.international@fmc-ag.com |
PDF Downloads
| Company report: FRESENIUS MEDICAL CARE AG & CO KGAA | |
Company Profile
Fresenius Medical Care AG & Co. KgaA engages in the provision of products and services for individuals with renal diseases of which regularly undergo dialysis treatment. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the healthcare services business. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany. |
Members of Management Board
| Carla Kriwet (ab 1.01.2023) | Chairman of Managing Board |
| Rice Powell | Chairman of Managing Board |
| Rice Powell (bis 31.12.2022) | Chairman of Managing Board |
| Katarzyna Mazur-Hofsäß | Member of Executive Committee |
| Olaf Schermeier | Member of Executive Committee |
| Rainer Runte | Member of Executive Committee |
| Dominik Wehner | Member of Executive Committee |
| Frank Maddux, MD | Member of Executive Committee |
| Helen Giza | Member of Executive Committee |
| Kent Wanzek | Member of Executive Committee |
| Michael Brosnan | Member of Executive Committee |
| Roberto Fusté | Member of Executive Committee |
| Ronald Kuerbitz | Member of Executive Committee |
| William Valle | Member of Executive Committee |
Board of directors
| Dieter Schenk | Chairman of Supervisory Board |
| A. Sorensen | Member of Supervisory Board |
| Dorothea Wenzel | Member of Supervisory Board |
| Gregor Zünd | Member of Supervisory Board |
| Pascale Witz | Member of Supervisory Board |
| Rolf Classon | Member of Supervisory Board |